Not sure if someone reported this already since it happened in April. It's good news that Darolutamide will hopefully be approved for at least one indication in the not-too-distant future. I spoke with my doctor about it last week and he said if it has FDA approval, he'll probably be able to get it for me even though I'm metastatic. Hopefully others will be able to get it as well. Hoping it gets approved soon.
The primary completion date of the study is currently September 14, 2018
For comparsion purposes: The SPARTAN trial for Apalutamide had a primary completion date of May 19, 2017 and was FDA approved on Feb. 14, 2018 nine months later.
Here's the article I saw: